Healthcare Tracked since Q4 FY26 - Q4 FY26

Senores Pharmaceuticals Ltd

SENORESPHARMACEUTICALS

Latest quarter Q4 FY26

Revenue ₹175 Cr (+62% YoY)

Management credibility Building

Needs more scored promises across 1 quarters

View all executive profiles for Senores Pharmaceuticals Ltd

Latest signal bullish high

Senores Pharmaceuticals delivered a stellar Q4 FY26, with consolidated revenue of 190 crores (up 66% YoY) and EBITDA...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 14 May 2026

Revenue ₹175 Cr (+62% YoY)

Senores Pharmaceuticals delivered a stellar Q4 FY26, with consolidated revenue of 190 crores (up 66% YoY) and EBITDA of 62 crores (up 3x YoY), driven by 83% growth in...

bullish high

Scorecard starts after historical backfill Read full analysis →